VTN and breast cancer: They inhibit the progression of abnormally proliferating epithelial cells, including DCIS, invasive cancer, and cancer-induced angiogenesis [93] by downregulating the expression and activity of matrix metalloproteinases (MMPs) in breast cancer (BC) cells and fibroblasts [90], and vitronectin-associated cell–matrix interactions, adhesion, and invasion [94].